Skip to main content

Table 3 Clinical characteristics of patients with COVID-19

From: Impact of COVID-19 on digestive system: prevalence, clinical characteristics, outcome, and relation to the severity of COVID-19

Characteristics

All patients

N=300

GI group

N=104

Non-GI group

N=196

P value

Symptoms, n (%)

 Fever

240

(80.0)

92

(88.5)

148

(75.5)

0.008*

 Anosmia

19

(6.3)

13

(12.5)

6

(3.1)

0.001*

 Cough

206

(68.7)

76

(73.1)

130

(66.3)

0.23

 Dyspnea

195

(65.0)

71

(68.3)

124

(63.3)

0.39

 Chest pain

5

(1.7)

1

(1.0)

4

(2.0)

0.49

 Runny nose

5

(1.7)

3

(.9)

2

(1.0)

0.23

 Sore throat

32

(10.7)

11

(10.6)

21

(10.7)

0.97

 Bony aches, myalgia

132

(44.0)

56

(53.8)

76

(38.8)

0.01*

 Low back pain

2

(0.7)

2

(0.7)

0

(0.0)

0.05

 Headache

19

(6.3)

10

(9.6)

9

(4.6)

0.09

 Lethargy, fatigue & malaise

21

(7.0)

7

(6.7)

14

(7.1)

0.89

 Dryness of mouth

2

(0.7)

2

(1.9)

0

(0.0)

0.05

 Metallic taste

1

(0.3)

1

(1.0)

0

(0.0)

0.17

 Hoarseness of voice

1

(0.3)

0

(0.0)

1

(0.3)

0.47

Gastrointestinal symptoms, n (%)

 Diarrhea

86

(28.7)

86

(82.7)

   

 Abdominal pain

15

(5)

15

(14.4)

   

 Nausea

16

(5.3)

16

(15.4)

   

 Vomiting

18

(6)

18

(17.3)

   

 Loss of appetite

9

(3)

9

(8.65)

   

 Loss of taste

13

(4.3)

13

(12.5)

   
  1. *Significant